Firefly Global is the foremost manufacturer and provider of high quality, affordable, wireless endoscopy cameras, digital video otoscopes, digital dermatoscopes, and telemedicine peripherals for organizations worldwide. Firefly wireless and wired cameras are small, easy to use and cost-effective, making them perfect candidates for small clinics, surgical centers, and remote deployments. Already popular in Ear-Nose-Throat, Primary Care, Urology, Audiology, Telehealth and Dermatology, Firefly products have been deployed in over 50 countries.
Firefly was founded from the idea to bring the latest technologies to the medical field at an affordable cost, making them broadly available. Kapriel Karagozyan, the Founder & CEO of Firefly, successfully bought this idea into reality with his wide expertise. Kapriel is an MIT graduate with a background in wireless technologies and advanced consumer electronics.
Market Leaders
Firefly develops and sells a variety of camera-based products uniquely suited for various telehealth applications. They are easy to use and easy to integrate, virtually plug-and-play with telehealth software platforms. While such products have been historically expensive to deploy, Firefly’s affordable portfolio of devices makes them an easy decision to include. Firefly does not charge license fees, which further simplifies system integration. Firefly’s overall approach enables broader deployment of telehealth peripherals, more so than previously possible.
Being the manufacturer and distributor of telehealth peripherals puts Firefly in a unique position to listen to its customers, gather feedback, and develop new products. One such product is the DE605 General Examination Camera. Uniquely suited for telehealth, this camera is based on years of input from industry experts and has already become one of their best-selling telehealth devices.
At an estimated value of over USD 4.53 billion in 2019, the Global Peripheral Artery Disease Market is predicted to thrive at a CAGR of 6.2% and valued at over USD 8.78 billion over the forecast year 2020-2030.Peripheral artery disease is a common circulatory problem that causes narrowing of the peripheral arteries.
Generally, it affects arteries in the legs and sometimes affect the arteries carrying blood from heart to arms, kidneys, head, and stomach.
It is mainly caused by the deposition of fats or plaques in the artery walls.
The exercise, tobacco cessation, and a healthy diet are the main treatments for this disease; however, when such treatments aren't enough, medication or surgery can be helpful.Access Full Description of this report at:- https://www.nextmsc.com/report/peripheral-artery-disease-market Top Companies: Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc., Terumo Corporation, Cook Medical, Becton, Dickinson and Company, Koninklijke Philips N.V, AngioDynamics, Inc., Biotronik and others.The global peripheral artery disease market share is segmented on the basis of type, and geography.
On the basis of type, the market is segmented into peripheral angioplasty balloons, peripheral catheters, inferior vena cava (IVC) filters, peripheral stents, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories.
Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.Request sample copy of this report at:- https://www.nextmsc.com/peripheral-artery-disease-market/request-sample In terms of geography, North America held major share of the market in 2019.
